Vaccine-focused Valneva consolidates R&D footprint by shuttering site, eliminating 30 roles
Vaccine-focused Valneva consolidates R&D footprint by shuttering site, eliminating 30 roles
Vaccine-focused Valneva consolidates R&D footprint by shuttering site, eliminating 30 roles